Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,035,911
  • Shares Outstanding, K 49,717
  • Annual Sales, $ 465,310 K
  • Annual Income, $ -44,700 K
  • EBIT $ -26 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.47
  • Price/Sales 4.38
  • Price/Cash Flow N/A
  • Price/Book 4.27

Options Overview Details

View History
  • Implied Volatility 57.56% (-2.76%)
  • Historical Volatility 49.49%
  • IV Percentile 24%
  • IV Rank 27.94%
  • IV High 112.50% on 11/05/25
  • IV Low 36.25% on 08/18/25
  • Expected Move (DTE 26) 2.51 (6.12%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 52
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,125
  • Open Int (30-Day) 890
  • Expected Range 38.44 to 43.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.04
  • Number of Estimates 4
  • High Estimate 0.01
  • Low Estimate -0.07
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.20 +23.34%
on 11/20/25
42.60 -3.87%
on 12/15/25
+6.77 (+19.81%)
since 11/19/25
3-Month
30.93 +32.37%
on 10/30/25
42.60 -3.87%
on 12/15/25
+4.52 (+12.41%)
since 09/19/25
52-Week
28.29 +44.75%
on 05/01/25
43.11 -5.01%
on 01/29/25
+10.90 (+36.27%)
since 12/19/24

Most Recent Stories

More News
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.95 (+1.36%)
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform

New technology combines Pulsed Field Ablation (PFA) and Advanced Radiofrequency Ablation with AtriCure’s EnCompass ® clamp to reduce treatment time for surgical ablation patients

ATRC : 40.95 (+1.36%)
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.95 (+1.36%)
AtriCure: Q3 Earnings Snapshot

AtriCure: Q3 Earnings Snapshot

ATRC : 40.95 (+1.36%)
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025

Worldwide revenue of $134.3 million – an increase of 15.8% year over year (15.1% constant currency) Net loss of $0.3 million – an improvement of $7.6 million year over year ...

ATRC : 40.95 (+1.36%)
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial

Trial will evaluate the safety and effectiveness of the AtriCure Isolator ® Synergy™ EnCompass ® clamp and AtriClip ® Left Atrial Appendage...

ATRC : 40.95 (+1.36%)
AtriCure to Participate in Upcoming Investor Conferences

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.95 (+1.36%)
AtriCure to Announce Third Quarter 2025 Financial Results

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.95 (+1.36%)
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation

New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need

ATRC : 40.95 (+1.36%)
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative...

ATRC : 40.95 (+1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 42.43
2nd Resistance Point 41.80
1st Resistance Point 41.37
Last Price 40.95
1st Support Level 40.32
2nd Support Level 39.69
3rd Support Level 39.26

See More

52-Week High 43.11
Last Price 40.95
Fibonacci 61.8% 37.45
Fibonacci 50% 35.70
Fibonacci 38.2% 33.95
52-Week Low 28.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar